Eugenol and other vanilloids hamper caenorhabditis elegans response to noxious heat by Nkambeu, Bruno et al.
 1 
Eugenol and Other Vanilloids Hamper Caenorhabditis elegans Response 
to Noxious Heat 
 
 
Bruno Nkambeu1,2, Jennifer Ben Salem1,2,3 and Francis Beaudry1,2* 
 
1- Groupe de Recherche en Pharmacologie Animal du Québec (GREPAQ), Département 
de Biomédecine Vétérinaire, Faculté de Médecine Vétérinaire, Université de Montréal, 
Saint-Hyacinthe, Québec, Canada 
 
2- Centre de recherche sur le cerveau et l’apprentissage (CIRCA), Université de 
Montréal, Montréal, Québec, Canada 
 
3- Institut des Maladies Métaboliques et Cardiovasculaires, INSERM UMR1048, 

















Francis Beaudry, Ph.D. 
Professor of analytical pharmacology 
Département de Biomédecine Vétérinaire 
Faculté de Médecine Vétérinaire 
Université de Montréal 
3200 Sicotte 
Saint-Hyacinthe, QC 






Keywords: Caenorhabditis elegans, Eugenol, Vanillin, Zingerone, Vanilloids, 




Eugenol, a known vanilloid, was frequently used in dentistry as a local analgesic in 
addition, antibacterial and neuroprotective effects were also reported. Eugenol, capsaicin 
and many vanilloids are interacting with the transient receptor potential vanilloid 1 
(TRPV1) in mammals and are activated by noxious heat. The pharmacological 
manipulation of the TRPV1 has been shown to have therapeutic value. Caenorhabditis 
elegans (C. elegans) express TRPV orthologs (e.g. OCR-2, OSM-9) and it is a commonly 
used animal model system to study nociception as it displays a well-defined and 
reproducible nocifensive behavior. After exposure to vanilloid solutions, C. elegans wild 
type (N2) and mutants were placed on petri dishes divided in quadrants for heat stimulation. 
Thermal avoidance index was used to phenotype each tested C. elegans experimental 
groups. The results showed that eugenol, vanillin and zingerone can hamper nocifensive 
response of C. elegans to noxious heat (32°C – 35°C) following a sustained exposition. 
Also, the effect was reversed 6h post exposition. Furthermore, eugenol and vanillin did not 
target specifically the OCR-2 or OSM-9 but zingerone did specifically target the OCR-2 
similarly to capsaicin. Further structural and physicochemical analyses were performed. 
Key parameters for quantitative structure-property relationships (QSPR), quantitative 
structure-activity relationships (QSAR) and frontier orbital analyses suggest similarities 
and dissimilarities amongst the tested vanilloids and capsaicin in accordance with the 






Caenorhabditis elegans (C. elegans) is a commonly used animal model system to study 
neuronal communication and more recently neurodegenerative diseases [1]. Adult self-
fertilizing hermaphrodite C. elegans consists of 959 cells, of which 302 are neurons, 
making this model very attractive to study nociception at the physiological level [2]. C. 
elegans males develop rarely (~ 0.1%). Likewise, C. elegans is especially useful to study 
nociception as it displays a well-defined and reproducible nocifensive behavior, involving 
a reversal and change in direction away from the noxious stimuli. C. elegans genome 
sequencing revealed the presence of several genes encoding TRP ion channel proteins with 
important sequence homologies to mammalian TRP channels including TRPVs [3]. 
Specifically, seven TRP subfamilies including TRPV orthologs (e.g. OSM-9 and OCR-1-
4) were characterized. Furthermore, it has been established that C. elegans TRP channels 
are associated with behavioral and physiological processes, including sensory transduction 
[4, 5]. Many C. elegans TRP channels share similar activation and regulatory mechanisms 
with higher species including mammals. Interestingly, our recent paper revealed that 
capsaicin can impede nocifensive response of C. elegans to noxious heat (i.e. 32°C – 35°C) 
following a sustained exposure and the effect was reversed 6h post capsaicin exposure [6]. 
Furthermore, capsaicin’s target was the C. elegans transient receptor potential channel 
OCR-2 and not OSM-9. Additional experiments showed anti-nociceptive effect for other 
capsaicin analogs, including olvanil, gingerol, shogaol and curcumin.  
 
In vivo animal testing is required early during the discovery phase in order to estimate some 
critical pharmacological parameters (e.g., volume of distribution, clearance, half-life, and 
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bioavailability) and evaluate efficacy and toxicity. However, in pain research, it is almost 
impossible to screen a complete compound library using a validated animal model of pain 
due to numerous limitations (e.g. ethical considerations, time limitation to allow the 
development of the pathological conditions, technical challenges associate with behavior 
evaluations and all associated cost). These limitations are an import burden for the 
development of new analgesics. The development of new analgesic drugs is becoming a 
priority due to the side effects of marketed drugs and a notable increase in the number of 
patients suffering from chronic pain [7, 8]. It is therefore essential to improve our capacity 
to test potential therapeutic effects on a larger number of molecules during the early 
discovery phase in order to better rank compounds for pre-clinical development, and 
therefore, significantly improve the success rate and eventually bring better drugs to relief 
patients. One long-term goal is to perform compound library synthesis using the vanillyl 
group as a primary template and leverage our core knowledge on TRPV1 ligands. Ligand-
receptor interactions are classically associated with the pharmacophore features and the 
vanillyl group has a fundamental role in vanilloids specific interaction with the TRPV1 [9, 
10]. Though, it is important to validate if C. elegans can be used as a predictive tool of 
drug efficacy and ultimately improve the animal-to-human translational success. 
 
Eugenol (4-allyl-2-methoxyphenol) is a vanilloids and it is one of the major constituents 
of clove oil (Eugenia aromatic) [11]. Eugenol was frequently used in dentistry as a local 
analgesic [12], moreover antibacterial [13] and neuroprotective effects [14] were also 
reported. The biphasic pharmacological effect of eugenol includes an initial pungent effect 
followed by a delayed analgesia and its chemical structure similar to capsaicin suggest that 
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both compounds are interacting with the same receptor, the transient receptor potential 
vanilloid 1 (TRPV1) in mammals [15]. Capsaicin and other vanilloids including eugenol 
pungent action is associated with the initial activation of the TRPV1 evoking membrane 
depolarization followed by the generation of action potential leading to heat and pain 
sensation. However, following sustained stimulation, TRPV1 agonists will elicit receptor 
desensitization, leading to alleviation of pain, a consequence of receptor conformational 
changes [37]. In recent years, we revealed that vanilloids can effectively alleviate pain in 
several animal models [16, 17, 18, 19, 20]. 
 
Our hypothesis is that heat avoidance behavior is regulated by TRPV ortholog channels in 
C. elegans and the exposure to eugenol and other vanilloids will hamper nocifensive 
response of C. elegans to noxious heat. The objective of this study is to characterize the 
targeted vanilloid exposure–response relationships using C. elegans and heat avoidance 
behavior analysis [21]. Selected vanilloids and known TRPV1 ligands that will be tested 
are displayed in Fig. 1. This study is important in order to demonstrate the adequacy of the 




Materials and Methods 
 
Chemicals and reagents 
All chemicals and reagents were obtained from Fisher Scientific (Fair Lawn, NJ, USA) or 
MilliporeSigma (St-Louis, MO, USA). Eugenol, vanillin and zingerone were purchased 
from Toronto Research Chemicals (North York, ON, CAN).  
 
C. elegans strains 
The N2 (Bristol) isolate of C. elegans was used as a reference strain. Mutant strains used 
in this study included: ocr-1 (ak46), ocr-2 (yz5), ocr-3 (ok1559), ocr-4 (vs137) and osm-9 
(yz6). N2 (Bristol) and other strains were obtained from the Caenorhabditis Genetics 
Center (CGC), University of Minnesota (Minneapolis, MN, USA). Strains were maintained 
and manipulated under standard conditions as described [22, 23]. Nematodes were grown 
and kept on Nematode Growth Medium (NGM) agar at 22˚C in a Thermo Scientific 
Heratherm refrigerated incubator. Experiments and analyses were performed at room 
temperature unless otherwise noted.  
 
C. elegans pharmacological manipulations 
Each vanilloid (i.e. eugenol, vanillin and zingerone) was dissolved in Type 1 Ultrapure 
Water at a concentration of 25 µM. The solution was warmed for brief periods combined 
with vortexing and sonication for several minutes to completely dissolve the compound. 
Then, dilution at 10 µM, 2 µM, 1 µM and 0.5 µM in Type 1 Ultrapure Water was performed 
by serial dilution for each compound. C. elegans were isolated and washed according to 
protocol outline by Margie et al. [23]. After 72 hours of feeding and growing on 92 x 16 
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mm petri dishes with NGM, the nematodes were exposed to vanilloids solutions. An aliquot 
of 7 mL of vanilloid solutions was added producing a 2-3 mm solution film (solution is 
partly absorbed by NGM), therefore, nematodes were swimming in solution. C. elegans 
were exposed for specific times, isolated and washed thoroughly prior behavior 
experiments. To test for the remanent effect (i.e. 6h latency), after exposure to solutions of 
eugenol, vanillin or zingerone, nematodes were isolated, carefully washed and deposit on 
NGM free of vanilloids. The NGM agar free of vanilloids with nematodes was kept at 22˚C 
in an incubator for 6h (i.e. remanent effect/latency test) and thermal avoidance response 
was retested. 
 
Thermal avoidance assay 
The method we proposed in this manuscript for the evaluation of thermal avoidance was 
modified from the four quadrants strategies previously described [23, 24] and used in 
previous successfully published work [6, 21, 25]. The experimental schematics are 
illustrated in supplementary Figure S1. Briefly, experiments were performed on 92 x 16 
mm petri dishes divided into four quadrants. A middle circle delimited (i.e. 1 cm diameter) 
an area where C. elegans were not considered. Petri dishes were divided into quadrants; 
two stimulus areas (A and D) and two control areas (B and C). Sodium azide (i.e. 0.5M) 
was used in all quadrants to paralyze the nematodes. Noxious heat was created with an 
electronically heated metal tip (0.8 mm diameter) producing a radial temperature gradient 
(e.g. 32-35˚C on the NGM agar at 2 mm from the tip measured with an infrared 
thermometer). Nematodes were isolated and washed according to a protocol outlined by 
Margie et al. [23]. The nematodes tested were off food during all experimentations. The 
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nematodes (i.e. 100 to 300 young adult worms) were placed at the center of a marked petri 
dish and after 30 minutes, they were counted per quadrant. Note that nematodes that did 
not cross the inner circle were not considered. The Thermal avoidance Index (TI) formula 
is shown in supplementary Figure S1. Both TI and the animal avoidance percentage were 
used to phenotype each tested C. elegans experimental groups. The stimulus temperature 
used was based on previous experiments [2, 6, 21, 25]. 
 
Statistical analysis 
Behavior data were analyzed using a one-way ANOVA followed by Dunnett multiple 
comparison test (e.g. WT(N2) was the control group used). For eugenol and its analogs, 
the data presented in Fig 4B were analyzed using a two-tailed Student's t-test (pairwise 
comparison). Significance was set a priori to p < 0.05. The statistical analyses were 
performed using PRISM (version 8.3). 
 
Molecular modeling 
The property calculations were performed using Spartan 18 software Wavefunction, Inc. 
Irvine, CA, USA [26]. Primary, the 3D space-filling models (i.e. CPK models) of capsaicin, 
eugenol, vanillin and zingerone were generated. Then, a systematic conformational search 
and analysis were performed to determine the more stable conformers for each compound, 
presenting the minima energy. Thus, the lowest energy conformer was obtained using 
MMFF molecular mechanics models by refining the geometry for each studied molecule. 
Using these structures optimized, calculations of molecular properties and topological 
descriptors were performed using density functional method [27], software algorithms 
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hybrid B3LYP model [27, 28, 29] and polarization basis set 6-31G* [26, 30] in a vacuum 
for equilibrium geometry at ground state. 
 
Results and discussion 
In our recent study, we have shown for the first-time, the anti-nociceptive effect of 
capsaicin in C. elegans following a controlled and prolonged exposure [6]. We also 
identified the capsaicin target, OCR-2. Additionally, other capsaicin analogs displayed 
similar anti-nociceptive effects. The use of capsaicin in patients is limited due to its pungent 
action creating a temporal intense pain sensation [31]. Interestingly, eugenol’s pungent 
action is significantly less compared to capsaicin [15]. This difference was associated with 
the smaller aliphatic chain at the C4 position of the vanillyl group. Thus, we wanted to 
verify if vanilloids with a shorter aliphatic chain at the C4 position of the vanillyl group 
conserve the anti-nociceptive effect in C. elegans while the pungent effect is reduced. This 
is particularly important in the spirit of drug discovery.   
 
The thermal avoidance assay performed is described in supplementary Figure S1 and was 
specifically used to assess if eugenol, vanillin or zingerone (e.g. selected vanilloids with a 
shorter aliphatic chain at the C4 position) could hamper nocifensive response to noxious 
heat. The first experiment included an assessment of the mobility and bias of WT (N2) and 
mutants ocr-1, ocr-2, ocr-3, ocr-4 and osm-9 nematodes in absence or in presence of 
eugenol, vanillin or zingerone. As shown in Figure 2, no quadrant selection bias was 
observed for all C. elegans experimental groups or genotypes tested with or without 
eugenol, vanillin or zingerone exposure (25 µM). Results showed that nematodes were not 
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selecting any specific quadrant and were uniformly distributed after 30 minutes following 
the initial nematode deposition at the center of the petri dish.  
 
After a prolonged stimulation, TRPV1 agonists elicit receptor desensitization, leading to 
alleviation of pain (or anti-nociceptive effect in C. elegans), which results from 
conformational changes, along with subsequent decrease of the release of pro-
inflammatory molecules and neurotransmitters following exposures to noxious stimuli [9, 
10, 32]. Therefore, we have exposed nematodes to eugenol (Figure 3A), vanillin (Figure 
3B) or zingerone (Figure 3C) in solution and consequently had complete control of time 
and exposure levels. As displayed in Figure 3, data revealed a dose–response relationship 
with a significant anti-nociceptive effect following a 1h exposure to all 3 vanilloids at 
concentrations ranging from 0.5 µM to 25 µM when compared with the WT (CTL) group. 
Significant differences in response were observed only for eugenol and zingerone as shown 
in Figure 3A and Figure 3C. Following eugenol, vanillin or zingerone exposition, 
nematodes were carefully washed and transferred on NGM agar kept at 22˚C in an 
incubator for 6h (i.e. residual effect/latency test). Then, the thermal avoidance response 
was retested. As shown in Figure 3, results suggest that after 6h post exposure to all 3 
vanilloids, C. elegans thermal avoidance response returned to normal. Thus, no residual 
anti-nociceptive effects of eugenol, vanillin or zingerone were observed after 6h. Eugenol, 
vanillin or zingerone initial sustained exposure is a key factor to observe vanilloid receptor 
desensitization as we have previously demonstrated for capsaicin [6].  
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Exposure–response relationship can be rationalized when we characterize the relationship 
involved in the target engagement of the tested molecule. Pharmacological effect can be 
measured when the tested molecule binds to a sufficient fraction of the target leading to a 
measurable response (i.e. physiological or phenotypic changes). Thus, experiments were 
conducted on specific C. elegans mutants (i.e. ocr-1, ocr-2, ocr-3, ocr-4 and osm-9) to 
potentially identify eugenol, vanillin or zingerone target receptors. C. elegans mutants were 
exposed to eugenol, vanillin or zingerone concentration of 25 µM for 60 min prior behavior 
experiments. As seen in Figure 4A, all mutants, except ocr-4 (vs137) appeared less 
sensitive to noxious heat compared with the WT (N2) group. However, they are still 
sensitive and may suggest redundancy in receptor function. There is no clear evidence 
eugenol (Figure 4B) or vanillin (Figure 4C) target a specific vanilloid ortholog receptors 
(e.g. OCR2 or OSM-9) since all tested mutants nocifensive responses to noxious heat were 
impeded following exposure to both molecules. The amplitude might be less important in 
ocr-2 mutant but no clear conclusion can be made based on these experiments. However, 
no significant zingerone effect (p > 0.05) was observed in ocr-2 mutant (Figure 4D) 
suggesting that zingerone targets ORC-2, a transient receptor potential channel, vanilloid 
subfamily and a mammalian capsaicin receptor-like channel as reported for capsaicin [6].  
Thermal nociceptive neurons express heat- and capsaicin-sensitive TRPV channels, OCR-
2 and OSM-9 are most likely the receptors targeted by vanilloids. These data sets clearly 
demonstrate anti-nociceptive effects of eugenol, vanillin and zingerone in C. elegans. The 
data shown in Figure 5 compared anti-nociceptive effect of capsaicin with eugenol, vanillin 
or zingerone at high concentration (i.e 10µM) and low concentration (i.e. 2µM). As shown, 
the difference is wider at low concentration (Figure 5B) suggesting significantly more 
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pronounced anti-nociceptive effect for vanillin and zingerone compared with capsaicin. 
Eugenol’s effect appeared more similar with capsaicin but still showed a more pronounced 
anti-nociceptive effect at low concentration (i.e. 2µM). These results are interesting since 
eugenol, vanillin and zingerone are significantly less pungent compared to capsaicin.   
 
Further structural and physicochemical analyses were performed. Key parameters for 
quantitative structure-property relationships (QSPR) and quantitative structure-activity 
relationships (QSAR) analysis are reported in Table 1. It was previously established [33], 
in order to increase success of drug candidates, that compounds should respect the 
following conditions: 1) maximum five hydrogen bond donors (as the total number of 
nitrogen-hydrogen and oxygen-hydrogen bonds); 2) maximum 10 hydrogen bond 
acceptors (as the total number of nitrogen and oxygen atoms); 3) the molecular weight 
should be lower than 500 Da; 4) the octanol-water partition coefficient (log P) value must 
be less than 5. Table 1 showed the calculated molecular properties from CPK and from 
Wavefunction models for capsaicin, eugenol, vanillin and zingerone obtained for the most 
stable conformer of each after geometry minimization: dipole moment, ovality, 
polarizability, the log P, the number of hydrogen bond donors (HBDs) and acceptor sites 
(HBAs), area, volume, polar surface area (PSA) and energies of frontier molecular orbitals 
(FMOs). Area and volume values are in the same ascending order then the respective 
molecular weights and increase in the following order: vanillin < eugenol < zingerone < 
capsaicin. However, PSA is not correlating with molecular weight order specifically for 
vanillin. PSA is associated with the interaction topography and potential steric hindrance 
[34]. A recent study suggests the PSA is a key descriptor to demystify relative biological 
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activity in a drug library composed of structurally related analogs [35]. Interestingly, the 
ratio between PSA and molecular weight paralleled with the observed relative anti-
nociceptive effect are shown in Figure 5.  However, the correlation between the PSA values 
or the ratio of the PSA and molecular weight values and the anti-nociceptive effect based 
on the current-set of molecules is not possible and would require a much larger training-
set to be statistically relevant. The ovality index characterizes the deviation from the 
spherical form, considering its value of 1 for an ideal spherical shape. From our 
calculations we observed the following variation of this parameter: 1.61 (capsaicin) < 1.37 
(zingerone) < 1.32 (eugenol) < 1.26 (vanillin). The ovality index is associated with 
molecular surface area and Van der Waals volume, and it increases with the increase of 
structural linearity explaining why capsaicin has the highest value. It is also an important 
parameter for potential steric hindrance and receptor binding specificity. Interestingly, as 
revealed in our previous study [6] and in Figure 4, only capsaicin and zingerone appear to 
specifically interact with OCR-2 while eugenol and vanillin are not interacting preferably 
with OCR-2.  Capsaicin and zingerone have higher ovality index values compared to 
eugenol and vanillin. Generally, the log P value is associated with the lipophilicity of a 
compound and it can be used to predict the drug absorption and distribution. Interestingly, 
the calculated log P values for capsaicin and eugenol are significantly higher compared to 
vanillin and zingerone. As shown in Figure 5, despite showing significant anti-nociceptive 
effect, capsaicin and eugenol have significantly less effect at 2µM compared to vanillin 
and zingerone. This may indicate that higher lipophilicity can affect the molecule’s ability 
to reach the target since a more important fraction of the molecules can be sequestered in 
animal fat compartments or by cell membrane components. All 4 tested molecules had log 
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P < 5, a criterion for a good drug candidate. The molecular frontier orbitals are important 
descriptors related to the reactivity of molecules and therefore center to explore ligand-
receptor interactions [35, 36]. The HOMO energy is linked to the tendency of a molecule 
to donate electrons to empty molecular orbitals of partner molecules. Conversely, the 
LUMO energy indicates the ability to accept electrons. The frontier molecular orbital 
density distribution of the studied compounds is shown in Figure 6 (HOMO) and Figure 7 
(LUMO) for capsaicin, eugenol, vanillin and zingerone. Red and blue areas relate to 
positive and negative values of the orbital. Interestingly, some distinct features appear for 
vanillin and zingerone with the group linked to C4 (para position from the hydroxy group) 
being able to accept electrons (LUMO) from partner molecules. The energy gap (DE = 
êHOMO-LUMO ê) obtained provided insight on relative stability and reactivity of the 
molecules. Accordingly, the higher value means the molecule is more stable and less 
reactive. The obtained energy gap increases in the order: eugenol (5.70) > capsaicin (5.67) 
> zingerone (4.92) and vanillin (4.67). These results suggest eugenol presents the lowest 
reactivity (the most chemically stable) followed by capsaicin, zingerone and vanillin (the 
most reactive). These results also appear coherent with the relative anti-nociceptive effect 
shown in Figure 5 keeping in mind the minute difference between capsaicin and eugenol 
at high concentration (10 µM). However, at low concentration (2µM) eugenol has a more 
pronounced anti-nociceptive effect compared to capsaicin but eugenol’s lower PSA and 
ovality, affecting steric hindrance, values may play an important role when comparing both 






This study clearly revealed eugenol’s, vanillin’s and zingerone’s anti-nociceptive effect in 
C. elegans following a controlled and prolonged exposition. These molecules effectively 
impede nocifensive response to noxious heat. Additionally, eugenol and vanillin did not 
target specifically the OCR-2 or OSM-9 but zingerone did specifically target the OCR-2 
similarly to capsaicin. However, functional redundancy between OCR-2 and OSM-9 is 
anticipated. As shown, the modeling of QSPR/QSAR properties and molecular frontier 
orbitals provide new understandings of vanilloids anti-nociceptive effects observed in C. 
elegans. These analyses are key chemoinformatics parameters to build a large vanilloid 
compound database to design drugs with desired biological properties. C. elegans could be 
used to rank these compounds for further evaluation in experimental models of pain and 
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Table 1. Predicted molecular properties for capsaicin, eugenol, vanillin and zingerone, 
using DFT method, B3LYP model using the 6-31G* basis set, in vacuum, for equilibrium 
geometry at ground state.  
 
 Capsaicin Eugenol Vanillin Zingerone 
Molecular properties 
Formula C18H27NO3 C10H12O2 C8H8O3  C11H14O3 
Molecular weight (amu) 305.418 164.204 152.149 194.230 
Energy (au) -982.596295 -538.697381 -535.318126 -653.261314 
Dipole moment (debye) 1.41 2.53 2.75 2.24 
E HOMO (eV) -5.57 -5.45 -6.07 -5.37 
E LUMO (eV) 0.10 0.25 -1.40 -0.45 
QSAR properties from CPK model 
Area (Å2) 382.96 207.17 175.13 232.78 
Volume (Å3) 346.53 184.38 154.14 209.37 
PSA (Å2) 48.746 24.408 38.963 37.973 
Ovality 1.61 1.32 1.26 1.37 
QSAR properties from computed electron density 
Log P 3.66 2.57 1.27 1.95 
HBD count 2 1 1 1 
HBA count 4 2 3 3 




Table 2. Capsaicin, eugenol, vanillin and zingerone energetic levels (eV) of intermediary 
molecular orbitals (MO).  
 
Orbital Capsaicin Eugenol Vanillin Zingerone 
LUMO{+3} 0.84 2.18 1.82 2.25 
LUMO{+2} 0.77 0.91 1.47 0.59 
LUMO{+1} 0.37 0.33 -0.07 0.39 
LUMO 0.10 0.25 -1.40 -0.45 
HOMO -5.57 -5.45 -6.07 -5.37 
HOMO{-1} -6.40 -6.31 -6.75 -6.24 
HOMO{-2} -6.45 -7.00 -6.86 -6.78 
HOMO{-3} -6.53 -8.41 -8.87 -8.33 
ΔE (êEHOMO–ELUMOç) (eV) 5.67 5.70 4.67 4.92 
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Figure 1. Molecular structure of known TRPV1 ligands capsaicin, eugenol, vanillin and 
zingerone. Ligand-receptor interactions are characteristically associated with the 
pharmacophore features and the vanillyl group play a fundamental role in interaction with 
the TRPV1. 
 
Figure 2. Comparison of the mobility and bias for WT (N2) and mutants ocr-1, ocr-2, ocr-
3, ocr-4 and osm-9 nematodes in plates divided into quadrants conserved at constant 
temperature (22˚C) and no stimulus was applied (negative control). No quadrant selection 
bias was observed for all C. elegans genotype tested in absence or presence of eugenol 
(Eug), vanillin (Van) or zingerone (Zin) at 25 µM. 
 
Figure 3. Assessment of the pharmacological effect of vanilloids on thermal avoidance in 
C. elegans. Nematodes were exposed to eugenol, vanillin or zingerone for 60 min prior 
behavior experimentations. A) Eugenol dose-response assessment. B) Vanillin dose-
response assessment. C) Zingerone dose-response assessment. Antinociceptive effect 
observed following C. elegans exposure to eugenol, vanillin or zingerone was dose 
dependent. Additionally, 6h post exposition, nociceptive behavior returns to normal for all 
doses and molecules tested. **** p < 0.0001, ** p < 0.01, *p < 0.05  (ANOVA - Tukey's 
multiple comparisons test). 
 
Figure 4. Identification of TRPV orthologs responsible for the anti-nociceptive effect 
observed for eugenol, vanillin and zingerone. A) Heat avoidance behavior phenotyping of 
tested mutants. Heat avoidance is partly impaired in each mutant, except for ocr-4(vs137). 
**** p < 0.0001, *** p < 0.001, *p < 0.05 (ANOVA - Dunnett's multiple comparison test) 
B) Eugenol-induced anti-nociceptive effect. C) Vanillin-induced anti-nociceptive effect. 
D) Zingerone-induced anti-nociceptive effect. Similarly, to capsaicin (Nkambeu et al. 
2020) the data suggest that zingerone exert is anti-nociceptive effects through the ORC-2 
C. elegans TRPV ortholog. However, results for eugenol and vanillin may indicate 
redundancy in receptor involvement. **** p < 0.0001, ** p < 0.01, *p < 0.05 (ANOVA - 
Sidak's multiple comparisons test). 
 
Figure 5. Assessment of the anti-nociceptive and desensitizing effects of vanilloid analogs 
of capsaicin (Cap). All molecules compared at 10 µM and 2µM produced significant anti-
nociceptive and desensitizing effects in C. elegans. Moreover, eugenol, vanillin and 
zingerone generate significantly more anti-nociceptive and desensitizing effects in C. 
elegans compared to capsaicin. **** p < 0.0001, *** p < 0.001 ** p < 0.01, *p < 0.05  
(ANOVA - Tukey's multiple comparisons test). 
 
Figure 6. HOMO orbital plots of capsaicin, eugenol, vanillin and zingerone using DFT 
method, B3LYP model and 6-31G* basis set, in vacuum for equilibrium geometry at 
ground state. Molecular orbitals provide important indications about chemical reactivity. 
The orbital drawing identifies regions where the orbital takes on a significant value, either 
positive (blue) or negative (red). 
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Figure 7. LUMO orbital plots of capsaicin, eugenol, vanillin and zingerone using DFT 
method, B3LYP model and 6-31G* basis set, in vacuum for equilibrium geometry at 
ground state. Molecular orbitals provide important indications about chemical reactivity. 
The orbital drawing identifies regions where the orbital takes on a significant value, either 
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